TANIA DEVILLIERS - 19 Sep 2023 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
INT PRIN ACCTG OFC
Signature
/s/ Tania DeVilliers
Issuer symbol
BIO
Transactions as of
19 Sep 2023
Net transactions value
$0
Form type
3
Filing time
27 Sep 2023, 16:07:11 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO Bio-Rad A Common Stock 55 19 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIO Restricted Stock Units 19 Sep 2023 Bio-Rad A Common Stock 82 $0.000000 Direct F1, F4
holding BIO Restricted Stock Units 19 Sep 2023 Bio-Rad A Common Stock 168 $0.000000 Direct F2, F4
holding BIO Restricted Stock Units 19 Sep 2023 Bio-Rad A Common Stock 311 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 1, 2021, the reporting person was granted 163 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F2 On September 1, 2022, the reporting person was granted 223 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F3 On September 1, 2023, the reporting person was granted 311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.